Global Oncology Precision Medicine Market Research Report 2025(Status and Outlook)

March 2025 | 193 pages | ID: GFF37581F1A4EN
Bosson Research

Abstracts

Report Overview

Oncology precision medicine refers to the customization of medical treatment to individual characteristics of each patient's tumor. This approach involves the use of genetic testing, molecular profiling, and other techniques to identify specific mutations or biomarkers that are driving the growth of a patient's cancer. By understanding the genetic makeup of a tumor, healthcare providers can tailor treatment plans to target the specific abnormalities present in each patient. Oncology precision medicine aims to improve treatment outcomes, minimize side effects, and optimize the overall effectiveness of cancer therapy.

The market for oncology precision medicine is experiencing significant growth driven by several key factors. Firstly, advancements in genomic sequencing technologies have made it more accessible and cost-effective to perform genetic testing on cancer patients. This has led to a growing adoption of precision medicine approaches in oncology practice. Secondly, there is a growing recognition of the limitations of traditional cancer treatments, such as chemotherapy, which are not always effective and can cause significant side effects. Oncology precision medicine offers a more targeted and personalized approach to cancer treatment, which is increasingly appealing to both patients and healthcare providers. Additionally, the increasing prevalence of cancer worldwide and the rising demand for more effective treatment options are further driving the growth of the oncology precision medicine market.

This report provides a deep insight into the global Oncology Precision Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Precision Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Precision Medicine market in any manner.

Global Oncology Precision Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Agilent Technologies

Almac

ANGLE plc

Asuragen

BGI Group

Bio-Rad Laboratories

BioMйrieux

Bristol Myers Squibb

Roche Holding AG

Gilead Sciences

Illumina

Konica Minolta

LabCorp

MDxHealth

Myriad Genetics

Novartis

OPKO Health

Pacific Biosciences

Quest Diagnostics

Qiagen

Market Segmentation (by Type)

Applied Sciences

Precision Diagnostics

Digital Health and Information Technology

Precision Therapeutics

Market Segmentation (by Application)

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Cervical Cancer

Other Cancer

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncology Precision Medicine Market
• Overview of the regional outlook of the Oncology Precision Medicine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Precision Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Precision Medicine
1.2 Key Market Segments
1.2.1 Oncology Precision Medicine Segment by Type
1.2.2 Oncology Precision Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Precision Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Precision Medicine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Oncology Precision Medicine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Precision Medicine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Oncology Precision Medicine Product Life Cycle
3.3 Global Oncology Precision Medicine Sales by Manufacturers (2020-2025)
3.4 Global Oncology Precision Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Precision Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Oncology Precision Medicine Manufacturing Sites, Area Served, Product Type
3.8 Oncology Precision Medicine Market Competitive Situation and Trends
3.8.1 Oncology Precision Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Precision Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Oncology Precision Medicine Industry Chain Analysis
4.1 Oncology Precision Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Precision Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Precision Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Oncology Precision Medicine Market
5.7 ESG Ratings of Leading Companies
6 Oncology Precision Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Precision Medicine Sales Market Share by Type (2020-2025)
6.3 Global Oncology Precision Medicine Market Size Market Share by Type (2020-2025)
6.4 Global Oncology Precision Medicine Price by Type (2020-2025)
7 Oncology Precision Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Precision Medicine Market Sales by Application (2020-2025)
7.3 Global Oncology Precision Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Precision Medicine Sales Growth Rate by Application (2020-2025)
8 Oncology Precision Medicine Market Sales by Region
8.1 Global Oncology Precision Medicine Sales by Region
8.1.1 Global Oncology Precision Medicine Sales by Region
8.1.2 Global Oncology Precision Medicine Sales Market Share by Region
8.2 Global Oncology Precision Medicine Market Size by Region
8.2.1 Global Oncology Precision Medicine Market Size by Region
8.2.2 Global Oncology Precision Medicine Market Size Market Share by Region
8.3 North America
8.3.1 North America Oncology Precision Medicine Sales by Country
8.3.2 North America Oncology Precision Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Precision Medicine Sales by Country
8.4.2 Europe Oncology Precision Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Precision Medicine Sales by Region
8.5.2 Asia Pacific Oncology Precision Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Precision Medicine Sales by Country
8.6.2 South America Oncology Precision Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Precision Medicine Sales by Region
8.7.2 Middle East and Africa Oncology Precision Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Oncology Precision Medicine Market Production by Region
9.1 Global Production of Oncology Precision Medicine by Region(2020-2025)
9.2 Global Oncology Precision Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Precision Medicine Production
9.4.1 North America Oncology Precision Medicine Production Growth Rate (2020-2025)
9.4.2 North America Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Precision Medicine Production
9.5.1 Europe Oncology Precision Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Precision Medicine Production (2020-2025)
9.6.1 Japan Oncology Precision Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Precision Medicine Production (2020-2025)
9.7.1 China Oncology Precision Medicine Production Growth Rate (2020-2025)
9.7.2 China Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Oncology Precision Medicine Product Overview
10.1.3 Abbott Laboratories Oncology Precision Medicine Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Basic Information
10.2.2 Agilent Technologies Oncology Precision Medicine Product Overview
10.2.3 Agilent Technologies Oncology Precision Medicine Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Almac
10.3.1 Almac Basic Information
10.3.2 Almac Oncology Precision Medicine Product Overview
10.3.3 Almac Oncology Precision Medicine Product Market Performance
10.3.4 Almac Business Overview
10.3.5 Almac SWOT Analysis
10.3.6 Almac Recent Developments
10.4 ANGLE plc
10.4.1 ANGLE plc Basic Information
10.4.2 ANGLE plc Oncology Precision Medicine Product Overview
10.4.3 ANGLE plc Oncology Precision Medicine Product Market Performance
10.4.4 ANGLE plc Business Overview
10.4.5 ANGLE plc Recent Developments
10.5 Asuragen
10.5.1 Asuragen Basic Information
10.5.2 Asuragen Oncology Precision Medicine Product Overview
10.5.3 Asuragen Oncology Precision Medicine Product Market Performance
10.5.4 Asuragen Business Overview
10.5.5 Asuragen Recent Developments
10.6 BGI Group
10.6.1 BGI Group Basic Information
10.6.2 BGI Group Oncology Precision Medicine Product Overview
10.6.3 BGI Group Oncology Precision Medicine Product Market Performance
10.6.4 BGI Group Business Overview
10.6.5 BGI Group Recent Developments
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Basic Information
10.7.2 Bio-Rad Laboratories Oncology Precision Medicine Product Overview
10.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product Market Performance
10.7.4 Bio-Rad Laboratories Business Overview
10.7.5 Bio-Rad Laboratories Recent Developments
10.8 BioMйrieux
10.8.1 BioMйrieux Basic Information
10.8.2 BioMйrieux Oncology Precision Medicine Product Overview
10.8.3 BioMйrieux Oncology Precision Medicine Product Market Performance
10.8.4 BioMйrieux Business Overview
10.8.5 BioMйrieux Recent Developments
10.9 Bristol Myers Squibb
10.9.1 Bristol Myers Squibb Basic Information
10.9.2 Bristol Myers Squibb Oncology Precision Medicine Product Overview
10.9.3 Bristol Myers Squibb Oncology Precision Medicine Product Market Performance
10.9.4 Bristol Myers Squibb Business Overview
10.9.5 Bristol Myers Squibb Recent Developments
10.10 Roche Holding AG
10.10.1 Roche Holding AG Basic Information
10.10.2 Roche Holding AG Oncology Precision Medicine Product Overview
10.10.3 Roche Holding AG Oncology Precision Medicine Product Market Performance
10.10.4 Roche Holding AG Business Overview
10.10.5 Roche Holding AG Recent Developments
10.11 Gilead Sciences
10.11.1 Gilead Sciences Basic Information
10.11.2 Gilead Sciences Oncology Precision Medicine Product Overview
10.11.3 Gilead Sciences Oncology Precision Medicine Product Market Performance
10.11.4 Gilead Sciences Business Overview
10.11.5 Gilead Sciences Recent Developments
10.12 Illumina
10.12.1 Illumina Basic Information
10.12.2 Illumina Oncology Precision Medicine Product Overview
10.12.3 Illumina Oncology Precision Medicine Product Market Performance
10.12.4 Illumina Business Overview
10.12.5 Illumina Recent Developments
10.13 Konica Minolta
10.13.1 Konica Minolta Basic Information
10.13.2 Konica Minolta Oncology Precision Medicine Product Overview
10.13.3 Konica Minolta Oncology Precision Medicine Product Market Performance
10.13.4 Konica Minolta Business Overview
10.13.5 Konica Minolta Recent Developments
10.14 LabCorp
10.14.1 LabCorp Basic Information
10.14.2 LabCorp Oncology Precision Medicine Product Overview
10.14.3 LabCorp Oncology Precision Medicine Product Market Performance
10.14.4 LabCorp Business Overview
10.14.5 LabCorp Recent Developments
10.15 MDxHealth
10.15.1 MDxHealth Basic Information
10.15.2 MDxHealth Oncology Precision Medicine Product Overview
10.15.3 MDxHealth Oncology Precision Medicine Product Market Performance
10.15.4 MDxHealth Business Overview
10.15.5 MDxHealth Recent Developments
10.16 Myriad Genetics
10.16.1 Myriad Genetics Basic Information
10.16.2 Myriad Genetics Oncology Precision Medicine Product Overview
10.16.3 Myriad Genetics Oncology Precision Medicine Product Market Performance
10.16.4 Myriad Genetics Business Overview
10.16.5 Myriad Genetics Recent Developments
10.17 Novartis
10.17.1 Novartis Basic Information
10.17.2 Novartis Oncology Precision Medicine Product Overview
10.17.3 Novartis Oncology Precision Medicine Product Market Performance
10.17.4 Novartis Business Overview
10.17.5 Novartis Recent Developments
10.18 OPKO Health
10.18.1 OPKO Health Basic Information
10.18.2 OPKO Health Oncology Precision Medicine Product Overview
10.18.3 OPKO Health Oncology Precision Medicine Product Market Performance
10.18.4 OPKO Health Business Overview
10.18.5 OPKO Health Recent Developments
10.19 Pacific Biosciences
10.19.1 Pacific Biosciences Basic Information
10.19.2 Pacific Biosciences Oncology Precision Medicine Product Overview
10.19.3 Pacific Biosciences Oncology Precision Medicine Product Market Performance
10.19.4 Pacific Biosciences Business Overview
10.19.5 Pacific Biosciences Recent Developments
10.20 Quest Diagnostics
10.20.1 Quest Diagnostics Basic Information
10.20.2 Quest Diagnostics Oncology Precision Medicine Product Overview
10.20.3 Quest Diagnostics Oncology Precision Medicine Product Market Performance
10.20.4 Quest Diagnostics Business Overview
10.20.5 Quest Diagnostics Recent Developments
10.21 Qiagen
10.21.1 Qiagen Basic Information
10.21.2 Qiagen Oncology Precision Medicine Product Overview
10.21.3 Qiagen Oncology Precision Medicine Product Market Performance
10.21.4 Qiagen Business Overview
10.21.5 Qiagen Recent Developments
11 Oncology Precision Medicine Market Forecast by Region
11.1 Global Oncology Precision Medicine Market Size Forecast
11.2 Global Oncology Precision Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Precision Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Precision Medicine Market Size Forecast by Region
11.2.4 South America Oncology Precision Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Precision Medicine by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Oncology Precision Medicine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Oncology Precision Medicine by Type (2026-2033)
12.1.2 Global Oncology Precision Medicine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Oncology Precision Medicine by Type (2026-2033)
12.2 Global Oncology Precision Medicine Market Forecast by Application (2026-2033)
12.2.1 Global Oncology Precision Medicine Sales (K Units) Forecast by Application
12.2.2 Global Oncology Precision Medicine Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Precision Medicine Market Size Comparison by Region (M USD)
Table 5. Global Oncology Precision Medicine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Oncology Precision Medicine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Oncology Precision Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Oncology Precision Medicine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2024)
Table 10. Global Market Oncology Precision Medicine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Oncology Precision Medicine Manufacturing Sites and Area Served
Table 12. Manufacturers Oncology Precision Medicine Product Type
Table 13. Global Oncology Precision Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Oncology Precision Medicine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Oncology Precision Medicine Sales by Type (K Units)
Table 25. Global Oncology Precision Medicine Market Size by Type (M USD)
Table 26. Global Oncology Precision Medicine Sales (K Units) by Type (2020-2025)
Table 27. Global Oncology Precision Medicine Sales Market Share by Type (2020-2025)
Table 28. Global Oncology Precision Medicine Market Size (M USD) by Type (2020-2025)
Table 29. Global Oncology Precision Medicine Market Size Share by Type (2020-2025)
Table 30. Global Oncology Precision Medicine Price (USD/Unit) by Type (2020-2025)
Table 31. Global Oncology Precision Medicine Sales (K Units) by Application
Table 32. Global Oncology Precision Medicine Market Size by Application
Table 33. Global Oncology Precision Medicine Sales by Application (2020-2025) & (K Units)
Table 34. Global Oncology Precision Medicine Sales Market Share by Application (2020-2025)
Table 35. Global Oncology Precision Medicine Market Size by Application (2020-2025) & (M USD)
Table 36. Global Oncology Precision Medicine Market Share by Application (2020-2025)
Table 37. Global Oncology Precision Medicine Sales Growth Rate by Application (2020-2025)
Table 38. Global Oncology Precision Medicine Sales by Region (2020-2025) & (K Units)
Table 39. Global Oncology Precision Medicine Sales Market Share by Region (2020-2025)
Table 40. Global Oncology Precision Medicine Market Size by Region (2020-2025) & (M USD)
Table 41. Global Oncology Precision Medicine Market Size Market Share by Region (2020-2025)
Table 42. North America Oncology Precision Medicine Sales by Country (2020-2025) & (K Units)
Table 43. North America Oncology Precision Medicine Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Oncology Precision Medicine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Oncology Precision Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Oncology Precision Medicine Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Oncology Precision Medicine Market Size by Region (2020-2025) & (M USD)
Table 48. South America Oncology Precision Medicine Sales by Country (2020-2025) & (K Units)
Table 49. South America Oncology Precision Medicine Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Oncology Precision Medicine Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Oncology Precision Medicine Market Size by Region (2020-2025) & (M USD)
Table 52. Global Oncology Precision Medicine Production (K Units) by Region(2020-2025)
Table 53. Global Oncology Precision Medicine Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Oncology Precision Medicine Revenue Market Share by Region (2020-2025)
Table 55. Global Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Abbott Laboratories Basic Information
Table 61. Abbott Laboratories Oncology Precision Medicine Product Overview
Table 62. Abbott Laboratories Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories SWOT Analysis
Table 65. Abbott Laboratories Recent Developments
Table 66. Agilent Technologies Basic Information
Table 67. Agilent Technologies Oncology Precision Medicine Product Overview
Table 68. Agilent Technologies Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies SWOT Analysis
Table 71. Agilent Technologies Recent Developments
Table 72. Almac Basic Information
Table 73. Almac Oncology Precision Medicine Product Overview
Table 74. Almac Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Almac Business Overview
Table 76. Almac SWOT Analysis
Table 77. Almac Recent Developments
Table 78. ANGLE plc Basic Information
Table 79. ANGLE plc Oncology Precision Medicine Product Overview
Table 80. ANGLE plc Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. ANGLE plc Business Overview
Table 82. ANGLE plc Recent Developments
Table 83. Asuragen Basic Information
Table 84. Asuragen Oncology Precision Medicine Product Overview
Table 85. Asuragen Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Asuragen Business Overview
Table 87. Asuragen Recent Developments
Table 88. BGI Group Basic Information
Table 89. BGI Group Oncology Precision Medicine Product Overview
Table 90. BGI Group Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. BGI Group Business Overview
Table 92. BGI Group Recent Developments
Table 93. Bio-Rad Laboratories Basic Information
Table 94. Bio-Rad Laboratories Oncology Precision Medicine Product Overview
Table 95. Bio-Rad Laboratories Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Recent Developments
Table 98. BioMйrieux Basic Information
Table 99. BioMйrieux Oncology Precision Medicine Product Overview
Table 100. BioMйrieux Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. BioMйrieux Business Overview
Table 102. BioMйrieux Recent Developments
Table 103. Bristol Myers Squibb Basic Information
Table 104. Bristol Myers Squibb Oncology Precision Medicine Product Overview
Table 105. Bristol Myers Squibb Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Bristol Myers Squibb Business Overview
Table 107. Bristol Myers Squibb Recent Developments
Table 108. Roche Holding AG Basic Information
Table 109. Roche Holding AG Oncology Precision Medicine Product Overview
Table 110. Roche Holding AG Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Roche Holding AG Business Overview
Table 112. Roche Holding AG Recent Developments
Table 113. Gilead Sciences Basic Information
Table 114. Gilead Sciences Oncology Precision Medicine Product Overview
Table 115. Gilead Sciences Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Gilead Sciences Business Overview
Table 117. Gilead Sciences Recent Developments
Table 118. Illumina Basic Information
Table 119. Illumina Oncology Precision Medicine Product Overview
Table 120. Illumina Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Illumina Business Overview
Table 122. Illumina Recent Developments
Table 123. Konica Minolta Basic Information
Table 124. Konica Minolta Oncology Precision Medicine Product Overview
Table 125. Konica Minolta Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Konica Minolta Business Overview
Table 127. Konica Minolta Recent Developments
Table 128. LabCorp Basic Information
Table 129. LabCorp Oncology Precision Medicine Product Overview
Table 130. LabCorp Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. LabCorp Business Overview
Table 132. LabCorp Recent Developments
Table 133. MDxHealth Basic Information
Table 134. MDxHealth Oncology Precision Medicine Product Overview
Table 135. MDxHealth Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. MDxHealth Business Overview
Table 137. MDxHealth Recent Developments
Table 138. Myriad Genetics Basic Information
Table 139. Myriad Genetics Oncology Precision Medicine Product Overview
Table 140. Myriad Genetics Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Myriad Genetics Business Overview
Table 142. Myriad Genetics Recent Developments
Table 143. Novartis Basic Information
Table 144. Novartis Oncology Precision Medicine Product Overview
Table 145. Novartis Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Novartis Business Overview
Table 147. Novartis Recent Developments
Table 148. OPKO Health Basic Information
Table 149. OPKO Health Oncology Precision Medicine Product Overview
Table 150. OPKO Health Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. OPKO Health Business Overview
Table 152. OPKO Health Recent Developments
Table 153. Pacific Biosciences Basic Information
Table 154. Pacific Biosciences Oncology Precision Medicine Product Overview
Table 155. Pacific Biosciences Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Pacific Biosciences Business Overview
Table 157. Pacific Biosciences Recent Developments
Table 158. Quest Diagnostics Basic Information
Table 159. Quest Diagnostics Oncology Precision Medicine Product Overview
Table 160. Quest Diagnostics Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Quest Diagnostics Business Overview
Table 162. Quest Diagnostics Recent Developments
Table 163. Qiagen Basic Information
Table 164. Qiagen Oncology Precision Medicine Product Overview
Table 165. Qiagen Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Qiagen Business Overview
Table 167. Qiagen Recent Developments
Table 168. Global Oncology Precision Medicine Sales Forecast by Region (2026-2033) & (K Units)
Table 169. Global Oncology Precision Medicine Market Size Forecast by Region (2026-2033) & (M USD)
Table 170. North America Oncology Precision Medicine Sales Forecast by Country (2026-2033) & (K Units)
Table 171. North America Oncology Precision Medicine Market Size Forecast by Country (2026-2033) & (M USD)
Table 172. Europe Oncology Precision Medicine Sales Forecast by Country (2026-2033) & (K Units)
Table 173. Europe Oncology Precision Medicine Market Size Forecast by Country (2026-2033) & (M USD)
Table 174. Asia Pacific Oncology Precision Medicine Sales Forecast by Region (2026-2033) & (K Units)
Table 175. Asia Pacific Oncology Precision Medicine Market Size Forecast by Region (2026-2033) & (M USD)
Table 176. South America Oncology Precision Medicine Sales Forecast by Country (2026-2033) & (K Units)
Table 177. South America Oncology Precision Medicine Market Size Forecast by Country (2026-2033) & (M USD)
Table 178. Middle East and Africa Oncology Precision Medicine Sales Forecast by Country (2026-2033) & (Units)
Table 179. Middle East and Africa Oncology Precision Medicine Market Size Forecast by Country (2026-2033) & (M USD)
Table 180. Global Oncology Precision Medicine Sales Forecast by Type (2026-2033) & (K Units)
Table 181. Global Oncology Precision Medicine Market Size Forecast by Type (2026-2033) & (M USD)
Table 182. Global Oncology Precision Medicine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 183. Global Oncology Precision Medicine Sales (K Units) Forecast by Application (2026-2033)
Table 184. Global Oncology Precision Medicine Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Oncology Precision Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Precision Medicine Market Size (M USD), 2024-2033
Figure 5. Global Oncology Precision Medicine Market Size (M USD) (2020-2033)
Figure 6. Global Oncology Precision Medicine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Precision Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Precision Medicine Product Life Cycle
Figure 13. Oncology Precision Medicine Sales Share by Manufacturers in 2024
Figure 14. Global Oncology Precision Medicine Revenue Share by Manufacturers in 2024
Figure 15. Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Oncology Precision Medicine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Precision Medicine Revenue in 2024
Figure 18. Industry Chain Map of Oncology Precision Medicine
Figure 19. Global Oncology Precision Medicine Market PEST Analysis
Figure 20. Global Oncology Precision Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Precision Medicine Market Share by Type
Figure 27. Sales Market Share of Oncology Precision Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Precision Medicine by Type in 2024
Figure 29. Market Size Share of Oncology Precision Medicine by Type (2020-2025)
Figure 30. Market Size Share of Oncology Precision Medicine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Precision Medicine Market Share by Application
Figure 33. Global Oncology Precision Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Precision Medicine Sales Market Share by Application in 2024
Figure 35. Global Oncology Precision Medicine Market Share by Application (2020-2025)
Figure 36. Global Oncology Precision Medicine Market Share by Application in 2024
Figure 37. Global Oncology Precision Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Precision Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Precision Medicine Market Size Market Share by Region (2020-2025)
Figure 40. North America Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oncology Precision Medicine Sales Market Share by Country in 2024
Figure 43. North America Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Precision Medicine Market Size Market Share by Country in 2024
Figure 45. U.S. Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Precision Medicine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Precision Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Precision Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Precision Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oncology Precision Medicine Sales Market Share by Country in 2024
Figure 53. Europe Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Precision Medicine Market Size Market Share by Country in 2024
Figure 55. Germany Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Precision Medicine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oncology Precision Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Precision Medicine Market Size Market Share by Region in 2024
Figure 68. China Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Precision Medicine Sales and Growth Rate (K Units)
Figure 79. South America Oncology Precision Medicine Sales Market Share by Country in 2024
Figure 80. South America Oncology Precision Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Precision Medicine Market Size Market Share by Country in 2024
Figure 82. Brazil Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Precision Medicine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oncology Precision Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Precision Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Precision Medicine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Precision Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oncology Precision Medicine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Oncology Precision Medicine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Oncology Precision Medicine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Oncology Precision Medicine Market Share Forecast by Type (2026-2033)
Figure 111. Global Oncology Precision Medicine Sales Forecast by Application (2026-2033)
Figure 112. Global Oncology Precision Medicine Market Share Forecast by Application (2026-2033)